Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Release Date:

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the October 11, 2022, issue.

Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more

Title
Paroxetine vs Quetiapine and Hypercapnia, SARS-CoV-2 Vaccination and COVID-19 Outcomes, USPSTF Recommendation on Anxiety in Children and Adolescents, and more
Copyright
Release Date

flashback